Sanofi Consumer Healthcare India Limited

SANOFICONR · Pharma · NSE

₹4,766

Current Market Price

Under Review— We don’t have enough data to publish a fair value estimate for SANOFICONR yet. Reason: Data Limited.

Valuation engine: DCF

Updated just now

YieldIQ Score

Piotroski F-Score

6/9

Economic Moat

Wide

Confidence

51%

ROE

62.5%

Debt/Equity

0.06

WACC

11.0%

Market Cap

₹10,976 Cr

Quality & Valuation

Neutral model outputs — no recommendations.

ROCE

81.7%

Return on capital employed

EV / EBITDA

30.6×

Enterprise multiple

Debt / EBITDA

0.1×

Leverage vs earnings

Interest Coverage

161.2×

EBIT covers interest

Current Ratio

3.85×

Short-term liquidity

Asset Turnover

1.61×

Revenue per ₹ of assets

Revenue CAGR (3Y)

3-year revenue growth

Revenue CAGR (5Y)

5-year revenue growth

Ratio Trends

SANOFICONR · last 3 annual periods

ROE

62.5%

min 16.2%max 79.4%

ROCE

81.7%

min 23.2%max 106.6%

Operating Margin

min max

Debt / Equity

0.06×

min 0.06×max 0.06×

PE

min max

EV / EBITDA

min max

Historical Financials

SANOFICONR · Annual, last 3 years· amounts in ₹Cr unless noted

Metric
2023
yfinance
2024
NSE_XBRL
2025
yfinance
CAGR
Revenue₹544 Cr₹725 Cr₹878 Cr+27.0%
EBITDA₹221 Cr₹255 Cr₹334 Cr+22.9%
EBIT₹251 Cr+0.0%
PAT₹165 Cr₹181 Cr₹240 Cr+20.7%
EPS (diluted)₹0.00
CFO₹-0.4 Cr₹439 Cr₹175 Cr
CapEx₹-4.0 Cr₹-9.9 Cr₹-7.6 Cr
FCF₹-4.4 Cr₹429 Cr₹167 Cr
Total Assets₹345 Cr₹431 Cr₹547 Cr+25.8%
Total Debt₹0.0 Cr₹20.3 Cr₹24.8 Cr
Shareholders' Equity₹208 Cr₹273 Cr₹384 Cr+36.0%

CAGR computed across the visible window. Signs reverse if start value is zero or negative.

Peer Comparison

SANOFICONR vs 3 closest peers by market-cap band

PeerMoSScoreVerdictROEPE
SANOFI

SANOFI

Pending43.6%
MARKSANS

MARKSANS

Pending13.8%
RUBICON

RUBICON

Pending

Click a ticker to view its fair-value analysis.

Dividend History

1 ex-dividend event on file. Source: NSE corporate-actions feed.

Total paid (5Y)

₹55.00/sh

Last payout

2025-04-17

₹55.00

Peak payout

₹55.00

Trailing yield

Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).

Run Full Interactive Analysis

Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.

Analyse SANOFICONRNow →

Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.